Souza, B.K.; Freire, N.H.; Monteiro, T.S.; Herlinger, A.L.; Jaeger, M.; Dalmolin, M.G.S.; de Farias, C.B.; Gregianin, L.; Brunetto, A.T.; Brunetto, A.L.;
et al. Histone Methyltransferases G9a/Ehmt2 and GLP/Ehmt1 Are Associated with Cell Viability and Poorer Prognosis in Neuroblastoma and Ewing Sarcoma. Int. J. Mol. Sci. 2023, 24, 15242.
https://doi.org/10.3390/ijms242015242
AMA Style
Souza BK, Freire NH, Monteiro TS, Herlinger AL, Jaeger M, Dalmolin MGS, de Farias CB, Gregianin L, Brunetto AT, Brunetto AL,
et al. Histone Methyltransferases G9a/Ehmt2 and GLP/Ehmt1 Are Associated with Cell Viability and Poorer Prognosis in Neuroblastoma and Ewing Sarcoma. International Journal of Molecular Sciences. 2023; 24(20):15242.
https://doi.org/10.3390/ijms242015242
Chicago/Turabian Style
Souza, Barbara Kunzler, Natalia Hogetop Freire, Thiago Santos Monteiro, Alice Laschuk Herlinger, Mariane Jaeger, Matheus G. S. Dalmolin, Caroline Brunetto de Farias, Lauro Gregianin, André T. Brunetto, Algemir L. Brunetto,
and et al. 2023. "Histone Methyltransferases G9a/Ehmt2 and GLP/Ehmt1 Are Associated with Cell Viability and Poorer Prognosis in Neuroblastoma and Ewing Sarcoma" International Journal of Molecular Sciences 24, no. 20: 15242.
https://doi.org/10.3390/ijms242015242
APA Style
Souza, B. K., Freire, N. H., Monteiro, T. S., Herlinger, A. L., Jaeger, M., Dalmolin, M. G. S., de Farias, C. B., Gregianin, L., Brunetto, A. T., Brunetto, A. L., Thiele, C. J., & Roesler, R.
(2023). Histone Methyltransferases G9a/Ehmt2 and GLP/Ehmt1 Are Associated with Cell Viability and Poorer Prognosis in Neuroblastoma and Ewing Sarcoma. International Journal of Molecular Sciences, 24(20), 15242.
https://doi.org/10.3390/ijms242015242
